Adverse events408

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 408

Type	Event	Organ system	Group	Affected	At risk	Events
other	10002272-Anemia	Blood and lymphatic system disorders	Dasatinib 100mg/Day + Cytarabine 200mg/m2/Day + Idarubicin 12mg/m2/Day	16	17	83
other	10002272-Anemia	Blood and lymphatic system disorders	Dasatinib 140mg/Day + Cytarabine 200mg/m2/Day + Idarubicin 12mg/m2/Day	3	3	3
other	10016288-Febrile neutropenia	Blood and lymphatic system disorders	Dasatinib 100mg/Day + Cytarabine 200mg/m2/Day + Idarubicin 12mg/m2/Day	5	17	12
other	10016288-Febrile neutropenia	Blood and lymphatic system disorders	Dasatinib 140mg/Day + Cytarabine 200mg/m2/Day + Idarubicin 12mg/m2/Day	0	3	0
other	Markedly irregular multilobulated spleen with linear calcification	Blood and lymphatic system disorders	Dasatinib 100mg/Day + Cytarabine 200mg/m2/Day + Idarubicin 12mg/m2/Day	0	17	0
other	Markedly irregular multilobulated spleen with linear calcification	Blood and lymphatic system disorders	Dasatinib 140mg/Day + Cytarabine 200mg/m2/Day + Idarubicin 12mg/m2/Day	1	3	1
other	Splenomegaly	Blood and lymphatic system disorders	Dasatinib 100mg/Day + Cytarabine 200mg/m2/Day + Idarubicin 12mg/m2/Day	1	17	1
other	Splenomegaly	Blood and lymphatic system disorders	Dasatinib 140mg/Day + Cytarabine 200mg/m2/Day + Idarubicin 12mg/m2/Day	0	3	0
other	10003658-Atrial fibrillation	Cardiac disorders	Dasatinib 100mg/Day + Cytarabine 200mg/m2/Day + Idarubicin 12mg/m2/Day	1	17	1
other	10003658-Atrial fibrillation	Cardiac disorders	Dasatinib 140mg/Day + Cytarabine 200mg/m2/Day + Idarubicin 12mg/m2/Day	0	3	0
other	10003662-Atrial flutter	Cardiac disorders	Dasatinib 100mg/Day + Cytarabine 200mg/m2/Day + Idarubicin 12mg/m2/Day	1	17	1
other	10003662-Atrial flutter	Cardiac disorders	Dasatinib 140mg/Day + Cytarabine 200mg/m2/Day + Idarubicin 12mg/m2/Day	0	3	0
other	10034474-Pericardial effusion	Cardiac disorders	Dasatinib 100mg/Day + Cytarabine 200mg/m2/Day + Idarubicin 12mg/m2/Day	1	17	2
other	10034474-Pericardial effusion	Cardiac disorders	Dasatinib 140mg/Day + Cytarabine 200mg/m2/Day + Idarubicin 12mg/m2/Day	2	3	2
other	10040741-Sinus bradycardia	Cardiac disorders	Dasatinib 100mg/Day + Cytarabine 200mg/m2/Day + Idarubicin 12mg/m2/Day	6	17	12
other	10040741-Sinus bradycardia	Cardiac disorders	Dasatinib 140mg/Day + Cytarabine 200mg/m2/Day + Idarubicin 12mg/m2/Day	0	3	0
other	10040752-Sinus tachycardia	Cardiac disorders	Dasatinib 100mg/Day + Cytarabine 200mg/m2/Day + Idarubicin 12mg/m2/Day	12	17	34
other	10040752-Sinus tachycardia	Cardiac disorders	Dasatinib 140mg/Day + Cytarabine 200mg/m2/Day + Idarubicin 12mg/m2/Day	1	3	1
other	Atherosclerotic Vascular Disease	Cardiac disorders	Dasatinib 100mg/Day + Cytarabine 200mg/m2/Day + Idarubicin 12mg/m2/Day	0	17	0
other	Atherosclerotic Vascular Disease	Cardiac disorders	Dasatinib 140mg/Day + Cytarabine 200mg/m2/Day + Idarubicin 12mg/m2/Day	1	3	1

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01876953/events

API reference For AI assistants

Adverse events408

Sources 3

Read this list from software.